β-Thalassemia: New Therapeutic Modalities, Genetics, Complications, and Quality of Life
Saved in:
Main Authors: | Mehran Karimi, Sezaneh Haghpanah, Ali T. Taher, Maria Domenica Cappellini |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Anemia |
Online Access: | http://dx.doi.org/10.1155/2012/902067 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial
by: John Porter, et al.
Published: (2012-01-01) -
Genetic Correction of Sickle Cell Anemia and β-Thalassemia: Progress and New Perspective
by: Ajay Perumbeti, et al.
Published: (2010-01-01) -
Ineffective Erythropoiesis in β-Thalassemia
by: Jean-Antoine Ribeil, et al.
Published: (2013-01-01) -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES
by: Ugo Testa, et al.
Published: (2024-08-01) -
Physiopathology of Bone Modifications in β-Thalassemia
by: Carlo Perisano, et al.
Published: (2012-01-01)